Q4 2023 Holdings
Filed 2024-02-14 | 47 holdings | $376.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $42.8M | 3,820,000 | 11.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $37.8M | 2,215,000 | 10.1% |
| Acelyrin Inc | COM | 00445A100 | $30.9M | 4,146,138 | 8.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $28.0M | 610,000 | 7.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $27.1M | 6,070,000 | 7.2% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $21.4M | 1,257,200 | 5.7% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $14.2M | 357,500 | 3.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $11.1M | 311,500 | 2.9% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $11.1M | 2,529,887 | 2.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $10.9M | 307,500 | 2.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $10.9M | 263,700 | 2.9% |
| Codexis Inc(CDXS) | COM | 192005106 | $9.3M | 3,045,525 | 2.5% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $8.6M | 200,000 | 2.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $7.6M | 699,000 | 2.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $7.3M | 897,000 | 1.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $6.3M | 1,960,000 | 1.7% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $6.3M | 308,500 | 1.7% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $6.1M | 563,500 | 1.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.7M | 90,000 | 1.5% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $5.4M | 445,000 | 1.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $5.0M | 2,692,594 | 1.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.8M | 320,000 | 1.3% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $4.6M | 250,000 | 1.2% |
| Applied Therapeutics(APLT) | COM | 03828A101 | $3.7M | 1,092,500 | 1.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $3.6M | 877,000 | 1.0% |
| Biodesix | COM | 09075X108 | $3.6M | 496,500 | 1.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.4M | 2,535,000 | 0.9% |
| Jasper Therapeutics Inc | COM | 471871103 | $3.1M | 3,985,340 | 0.8% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $3.0M | 99,000 | 0.8% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $3.0M | 265,388 | 0.8% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $2.9M | $8,000,000 | 0.8% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $2.8M | 623,500 | 0.8% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $2.8M | 1,140,000 | 0.7% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $2.8M | 359,370 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $2.7M | 2,982,200 | 0.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.6M | 112,700 | 0.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.8M | 150,000 | 0.5% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.7M | 211,400 | 0.5% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $1.6M | 344,800 | 0.4% |
| Morphosys AG | SPONSORED ADS | 617760202 | $1.4M | 145,000 | 0.4% |
| Precigen Inc(PGEN) | COM | 74017N105 | $1.4M | 1,012,500 | 0.4% |
| Sutro Biopharma Inc | COM | 869367102 | $1.3M | 301,491 | 0.3% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.1M | 975,000 | 0.3% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $877.5K | 130,000 | 0.2% |
| Aligos Therapeutics Inc | COM | 01626L105 | $861.2K | 1,297,000 | 0.2% |
| Kiniksa Pharmaceuticals LTD | COM CLASS A | G5269C101 | $640.2K | 37,500 | 0.2% |